Predict your next investment

PZM Diagnostics company logo
HEALTHCARE | Disease Diagnosis
crohnsmanagement.com

See what CB Insights has to offer

Stage

Incubator/Accelerator | Alive

About PZM Diagnostics

PZM Diagnostics provides testing for antibacterial antibodies with the goal to change the direction of diagnosis and therapy of Crohn's and other autoimmune disease.

PZM Diagnostics Headquarter Location

500 Donnally St. Suite 303

Charleston, West Virginia, 25301,

United States

304-444-7505

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing PZM Diagnostics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

PZM Diagnostics is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

7,884 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

PZM Diagnostics Patents

PZM Diagnostics has filed 3 patents.

The 3 most popular patent topics include:

  • Acid fast bacilli
  • Autoimmune diseases
  • Nontuberculous mycobacteria
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/21/2017

9/29/2020

Nontuberculous mycobacteria, Acid fast bacilli, Autoimmune diseases, Glucocorticoids, Inflammations

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

11/21/2017

00/00/0000

00/00/0000

Grant Date

9/29/2020

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

Nontuberculous mycobacteria, Acid fast bacilli, Autoimmune diseases, Glucocorticoids, Inflammations

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.